What is the current stock price of Kringle Pharma, Inc. (4884.T)?

As of the latest market data, Kringle Pharma, Inc. (4884.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Kringle Pharma, Inc. (4884.T) pay a dividend?

Based on current data, Kringle Pharma, Inc. does not have a confirmed active dividend policy.

What is the market cap of Kringle Pharma, Inc.?

The current market capitalization of Kringle Pharma, Inc. (4884.T) is approximately unavailable.

4884.T

Kringle Pharma, Inc.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2020-12-28

Beta

0.28

Websitewww.kringle-pharma.com↗